跳至主要内容
临床试验/JPRN-UMIN000026040
JPRN-UMIN000026040招募中未知

Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancer - Biomarker studies for nivolumab

Kagoshima University0 个研究点目标入组 90 人开始时间: 2017年2月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Subjects with autoimmune disease. (2)Subjects with interstitial lung disease. (3)Receiving continuous systemic corticosteroid. (4)Prior therapy with antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways. (5)Patients with a history of hypersensitivity to nivolumab. (6)Dementia or psychological disorder difficult to participate in this clinical study.

研究者

相似试验